Leone, Antonio Maria
 Distribuzione geografica
Continente #
NA - Nord America 11.339
EU - Europa 9.766
AS - Asia 8.654
SA - Sud America 1.601
AF - Africa 226
Continente sconosciuto - Info sul continente non disponibili 27
OC - Oceania 27
Totale 31.640
Nazione #
US - Stati Uniti d'America 11.032
DE - Germania 4.142
SG - Singapore 4.125
CN - Cina 1.977
BR - Brasile 1.278
SE - Svezia 1.232
IT - Italia 1.039
FR - Francia 838
VN - Vietnam 782
UA - Ucraina 536
GB - Regno Unito 496
IE - Irlanda 359
IN - India 270
ID - Indonesia 259
FI - Finlandia 247
BD - Bangladesh 240
PL - Polonia 210
JP - Giappone 205
RU - Federazione Russa 182
HK - Hong Kong 165
TR - Turchia 142
AR - Argentina 141
CA - Canada 140
NL - Olanda 100
MX - Messico 93
IQ - Iraq 89
AT - Austria 70
BE - Belgio 59
ES - Italia 57
KR - Corea 53
ZA - Sudafrica 46
CO - Colombia 42
VE - Venezuela 38
IR - Iran 37
JO - Giordania 37
MA - Marocco 37
PK - Pakistan 34
EG - Egitto 33
EC - Ecuador 32
SA - Arabia Saudita 28
CH - Svizzera 27
LT - Lituania 27
UZ - Uzbekistan 27
CI - Costa d'Avorio 22
JM - Giamaica 22
PY - Paraguay 22
AU - Australia 21
AE - Emirati Arabi Uniti 20
KE - Kenya 18
PE - Perù 18
CL - Cile 17
EU - Europa 17
PH - Filippine 17
ET - Etiopia 16
LB - Libano 15
TN - Tunisia 15
IL - Israele 14
KZ - Kazakistan 13
RO - Romania 13
MY - Malesia 12
AL - Albania 11
AZ - Azerbaigian 11
BG - Bulgaria 11
CZ - Repubblica Ceca 11
GR - Grecia 11
HN - Honduras 11
HU - Ungheria 11
KG - Kirghizistan 10
LV - Lettonia 10
BY - Bielorussia 9
NO - Norvegia 9
BO - Bolivia 8
DO - Repubblica Dominicana 8
DZ - Algeria 8
MD - Moldavia 8
OM - Oman 8
RS - Serbia 8
CR - Costa Rica 7
DK - Danimarca 7
LU - Lussemburgo 7
NG - Nigeria 7
NP - Nepal 7
QA - Qatar 7
PA - Panama 6
PS - Palestinian Territory 6
TH - Thailandia 6
AM - Armenia 5
HR - Croazia 5
MN - Mongolia 5
NZ - Nuova Zelanda 5
SK - Slovacchia (Repubblica Slovacca) 5
TW - Taiwan 5
UY - Uruguay 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AO - Angola 4
CG - Congo 4
KW - Kuwait 4
NI - Nicaragua 4
SN - Senegal 4
TT - Trinidad e Tobago 4
Totale 31.581
Città #
Singapore 2.387
Chandler 1.702
San Jose 1.122
Ashburn 1.072
New York 426
Beijing 403
Dublin 352
San Mateo 336
Jacksonville 287
Ho Chi Minh City 268
Los Angeles 261
Nürnberg 244
Lauterbourg 230
Jakarta 226
Hanoi 210
Nanjing 210
Rome 203
Hefei 198
Munich 198
Tokyo 183
Wilmington 183
The Dalles 167
Ann Arbor 162
Boston 162
Marseille 160
Frankfurt am Main 157
Milan 151
Warsaw 147
Hong Kong 143
Dallas 127
Cattolica 126
Moscow 120
Houston 110
St Louis 106
São Paulo 102
Dearborn 96
Nanchang 96
Woodbridge 90
Lawrence 89
Buffalo 88
Santa Clara 87
Princeton 85
Lancaster 80
Bremen 79
Izmir 79
Seattle 79
Helsinki 76
Redwood City 70
Chicago 67
Orem 65
Fairfield 62
Nuremberg 60
Brussels 55
Kent 54
Paris 53
Leawood 51
Boardman 50
Seoul 49
Shanghai 49
Turku 49
Vienna 45
London 44
Rio de Janeiro 43
Amsterdam 42
Düsseldorf 42
San Francisco 42
Atlanta 41
Brooklyn 41
Detroit 40
Phoenix 40
Zhengzhou 40
Montreal 39
Tianjin 39
Baghdad 38
Da Nang 37
Hebei 37
Mountain View 36
Norwalk 36
Amman 35
Guangzhou 35
Kraków 35
Toronto 35
Chennai 33
Denver 33
Kunming 32
University Park 31
Curitiba 30
Shenyang 30
Washington 30
Andover 27
Hangzhou 27
Poplar 27
Stockholm 27
Johannesburg 26
Naples 26
Augusta 25
Brasília 25
Changsha 25
Dhaka 25
Jiaxing 25
Totale 15.765
Nome #
Impact of operator experience and wiring technique on procedural efficacy of trans-radial percutaneous chronic total occlusion recanalization performed by dedicated radialists 302
Right ventricular-pulmonary artery coupling assessed by two-dimensional strain predicts in-hospital complications in Takotsubo syndrome 278
Comparison of Right and Left Upper Limb Arterial Variants in Patients Undergoing Bilateral Transradial Procedures 272
Anti-tissue transglutaminase antibodies from celiac patients are responsible for trophoblast damage via apoptosis in vitro 271
Management of the access site after transradial percutaneous procedures: literature overview 267
Safety and efficacy of G-CSF in patients with ischemic heart failure: The CORNER (Cell Option for Recovery in the Non-Eligible patients for Revascularization) study. 264
Clinical and procedural impact of aortic arch anatomic variants in carotid stenting procedures 259
Frequency domain optical coherence tomography to assess non-ostial left main coronary artery 250
Prospective evaluation of myocardial ischemia related to post-procedural side-branch stenosis in bifurcated lesions treated by provisional approach with drug-eluting stents. 247
Renal artery stenting in patients with chronic ischemic heart disease 242
Baseline C-Reactive Protein Serum Levels and In-Stent Restenosis Pattern After m-TOR Inhibitors Drug-Eluting Stent Implantation 242
The HEART study: a real-world experience using the CID Chrono Carbostent in primary and rescue PCI 240
Ticagrelor and preconditioning in patients with stable coronary artery disease (TAPER-S): A randomized pilot clinical trial 237
Differences in Microparticle Release in Patients With Acute Coronary Syndrome and Stable Angina 236
Management and timing of access-site vascular complications occurring after trans-radial percutaneous coronary procedures 234
Human cardiac progenitor cells with regenerative potential can be isolated and characterized from 3D-electro-anatomic guided endomyocardial biopsies 233
Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate 228
Euroscore as predictor of in-hospital mortality after percutaneous coronary intervention 220
A case of fatal stent thrombosis after Carbostent implantation: Is clopidogrel alone antiplatelet therapy a safe alternative to aspirin alone antiplatelet therapy 217
Outcome of non-cardiac surgery after stent implantation in the DES era: results of the Surgery After Stent (SAS) registry 217
Effects of bariatric surgery on cardiac remodeling: clinical and pathophysiologic implications 217
Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents 214
Optical coherence tomography features of angiographic complex and smooth lesions in acute coronary syndromes 212
Vascular complications and access crossover in 10,676 transradial percutaneous coronary procedures 210
Angiographic and clinical outcome of percutaneous coronary intervention for in-stent restenosis of bifurcated lesions 209
Endothelial progenitor cells in morbid obesity 201
Concordance of angiographic and electrocardiographic indexes of microvascular obstruction: myocardial haemorrhage role 201
Procedural and clinical evaluation of the novel zotarolimus-eluting resolute stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: a multicenter registry 200
Euroscore as predictor of in-hospital mortality after percutaneous coronary intervention 200
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 196
Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery 195
Fractional Flow Reserve or Optical Coherence Tomography to Guide Management of Angiographically Intermediate Coronary Stenosis: A Single-Center Trial 191
Characterization of microvascular and myocardial damage within perfusion defect area at myocardial contrast echocardiography in the subacute phase of myocardial infarction 190
Efficacy of contrast medium induced Pd/Pa ratio in predicting functional significance of intermediate coronary artery stenosis assessed by fractional flow reserve: insights from the RINASCI study 190
Eosinophil cationic protein and clinical outcome after bare metal stent implantation 188
In vitro cardiomyocyte differentiation of umbilical cord blood cells: crucial role for c-kit(+) cells 187
Safety of granulocyte-colony-stimulating factor in acute myocardial infarction (the Rigenera study). 184
A current approach to heart failure in Duchenne muscular dystrophy 183
Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention 182
Case-control registry of excimer laser coronary angioplasty versus distal protection devices in patients with acute coronary syndromes due to saphenous vein graft disease 180
Are endothelial progenitor cells mobilized by myocardial ischemia or myocardial necrosis? A cardiac magnetic resonance study 179
Coronary Atherosclerotic Phenotype and Plaque Healing in Patients with Recurrent Acute Coronary Syndromes Compared with Patients with Long-term Clinical Stability: An in Vivo Optical Coherence Tomography Study 179
Angiographically intermediate left main bifurcation disease assessment by frequency domain optical coherence tomography (FD-OCT) 178
Three-dimensional quantitative coronary angiography and quantification of jeopardised myocardium to predict functional significance of intermediate coronary artery stenosis 177
Coronary bifurcation lesions: to stent one branch or both? A meta-analysis of patients treated with drug eluting stents. 176
Myocardial bridge evaluation towards personalized medicine: study design and preliminary results of the RIALTO registry 172
Eosinophil cationic protein and clinical outcome after bare metal stent implantation 172
Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study). 172
Anti-transglutaminase antibodies from celiac patients are responsible for trophoblast damage via apoptosis in vitro 172
Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function 171
Effects of late REopening of Coronary total Occlusion on micRovascular perfusion and myocarDial function: the RECORD study 171
Angiographic assessment of myocardial perfusion in Tako-Tsubo syndrome 170
Interplay Between Myocardial Bridging and Coronary Spasm in Patients With Myocardial Ischemia and Non-Obstructive Coronary Arteries: Pathogenic and Prognostic Implications 170
Adenosine as adjunctive therapy in acute coronary syndrome: a meta-analysis of randomized controlled trials 169
Efficacy of contrast medium induced Pd/Pa ratio in predicting functional significance of intermediate coronary artery stenosis assessed by fractional flow reserve: insights from the RINASCI study 169
Plaque rupture and intact fibrous cap assessed by optical coherence tomography portend different outcomes in patients with acute coronary syndrome 168
Limitations of noninvasive measurement of fractional flow reserve from coronary computed tomography angiography 167
Concordance of angiographic and electrocardiographic indexes of microvascular obstruction: myocardial haemorrhage role 167
Corrigendum to 'Morphological and functional consequences of transradial coronary angiography on the radial artery: implications for its use as a bypass conduit' [Eur J Cardiothorac Surg 2015;48:370-4]† 167
Impact of coronary stenting on top of medical therapy and of inclusion of periprocedural infarctions on hard composite endpoints in patients with chronic coronary syndromes: a meta-analysis of randomized controlled trials 167
Parvovirus B19 at the culprit coronary stenosis predicts outcome after stenting 164
Resolute zotarolimus-eluting stent to treat bifurcated lesions according to the provisional technique: a procedural performance comparison with sirolimus- and everolimus-eluting stents 163
Ethanol abolishes ischemic preconditioning in humans 162
Baseline inflammatory status and long-term changes in renal function after percutaneous renal artery stenting: A prospective study 162
Frequency-domain optical coherence tomography findings in patients with bifurcated lesions undergoing provisional stenting 161
EuroSCORE predicts long-term mortality of unselected patients undergoing percutaneous coronary interventions 161
Clinical, angiographic and echocardiographic correlates of epicardial and microvascular spasm in patients with myocardial ischaemia and non-obstructive coronary arteries 161
Impact of drug-eluting balloon (pre- or post-) dilation on neointima formation in de novo lesions treated by bare-metal stent: the IN-PACT CORO trial 160
Influence of the amount of myocardium subtended by a stenosis on fractional flow reserve 159
Correlation between CD4 + CD28 null T lymphocytes, regulatory T cells and plaque rupture: An Optical Coherence Tomography study in Acute Coronary Syndromes 159
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study 156
Differential levels of circulating progenitor cells in acute coronary syndrome patients with a first event versus patients with recurring events 155
Human cardiac progenitor cells with regenerative potential can be isolated and characterized from 3D-electro-anatomic guided endomyocardial biopsies 155
No-reflow reversibility: a study based on serial assessment of multiple biomarkers 154
Safety and prognostic relevance of acetylcholine testing in patients with stable myocardial ischaemia or myocardial infarction and non-obstructive coronary arteries 154
Three-dimensional quantitative coronary angiography and quantification of jeopardised myocardium to predict functional significance of intermediate coronary artery stenosis 153
Predictors of fractional flow reserve/instantaneous wave-free ratio discordance: impact of tailored diagnostic cut-offs on clinical outcomes of deferred lesions 153
From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells 152
Effect of Exercise on Circulating Endothelial Progenitor Cells in Microvascular Angina 152
Radial artery complications occurring after transradial coronary procedures using long hydrophilic-coated introducer sheath: a frequency domain-optical coherence tomography study 152
Predictors of periprocedural (type IVa) myocardial infarction, as assessed by frequency-domain optical coherence tomography 151
Infarct-related artery occlusion, tissue markers of ischemia, and increased apoptosis in the peri-infarct viable myocardium. 151
Coronary Microvascular Dysfunction Is Associated With a Worse Cardiac Phenotype in Patients With Fabry Disease 150
Differential levels of circulating progenitor cells in acute coronary syndrome patients with a first event versus patients with recurring events 148
Endothelial progenitor cells, microvascular obstruction, and left ventricular remodeling in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention 148
Clinical Impact of Heart Team Decisions for Patients With Complex Valvular Heart Disease: A Large, Single-Center Experience 147
Outcome of overlapping heterogenous drug-eluting stents and of overlapping drug-eluting and bare metal stents. 147
Anti-tissue transglutaminase antibodies from celiac patients are responsible for trophoblast damage via apoptosis in vitro 146
Association between inflammatory biomarkers and in-stent restenosis tissue features: an Optical Coherence Tomography Study 145
Effects of late REopening of Coronary total Occlusion on micRovascular perfusion and myocarDial function: the RECORD study 144
Frequency-domain optical coherence tomography assessment of kissing-balloon effects in bifurcated coronary artery lesions undergoing provisional stenting 144
Response to letter regarding article, "growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery" 144
Coronary Atherosclerotic Phenotype and Plaque Healing in Patients with Recurrent Acute Coronary Syndromes Compared with Patients with Long-term Clinical Stability: An in Vivo Optical Coherence Tomography Study 143
Management and timing of access-site vascular complications occurring after trans-radial percutaneous coronary procedures 142
Impact of accuracy of fractional flow reserve to reduction of microvascular resistance after intracoronary adenosine in patients with angina pectoris or non-ST-segment elevation myocardial infarction 142
The combined effect of subcutaneous granulocyte- colony stimulating factor and myocardial contrast echocardiography with intravenous infusion of sulfur hexafluoride on post-infarction left ventricular function, the RIGENERA 2.0 trial: study protocol for a randomized controlled trial 142
Fractional flow reserve or optical coherence tomography guidance to revascularize intermediate coronary stenosis using angioplasty (FORZA) trial: study protocol for a randomized controlled trial 139
Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction) 137
Effect of exercise on circulating endothelial progenitor cells in microvascular angina 137
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study 137
Totale 18.351
Categoria #
all - tutte 125.065
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.065


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.876 127 112 35 100 98 63 57 333 70 143 336 402
2022/20234.182 525 615 363 689 190 521 231 352 514 38 87 57
2023/20242.107 82 520 74 86 82 401 125 109 51 69 269 239
2024/20254.567 94 143 309 212 384 129 146 243 724 464 1.011 708
2025/202611.693 1.701 333 643 1.271 2.006 565 2.090 552 764 802 541 425
2026/2027153 153 0 0 0 0 0 0 0 0 0 0 0
Totale 32.080